Study of ZGGS34 in Participants With Advanced Solid Tumors
Clinical trial NCT07258121 · RECRUITING
Trial details
- NCT number
- NCT07258121
- Sponsor
- Suzhou Zelgen Biopharmaceuticals Co.,Ltd
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-31
- Primary completion
- 2028-12-01
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.